BlackRock, Inc.

Position in RLMD — Relmada Therapeutics, Inc.

CIK 2012383 New York, NY

Position in RLMD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$51,393,314

+$42,418,049 QoQ

Shares Held

7,426,780

+475.9% QoQ

Ownership

6.96%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 126 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,603,777,939 across 474 Biotechnology names. RLMD ranks #164 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$50,882,157	7,352,913	—	Shares	Sole	2026-07-29
2026-06-30	$51,393,314	7,426,780	+475.9%	Shares	Sole	2026-08-07
2026-03-31	$8,975,265	1,289,550	+1.7%	Shares	Sole	2026-05-13
2025-12-31	$6,122,038	1,267,503	+149.5%	Shares	Sole	2026-02-12
2025-09-30	$1,021,080	508,000	0.0%	Shares	Sole	2025-11-12
2025-06-30	$304,800	508,000	-10.4%	Shares	Sole	2025-08-12
2025-03-31	$153,064	566,905	-4.5%	Shares	Sole	2025-05-02
2024-12-31	$308,526	593,326	+4.5%	Shares	Sole	2025-02-07
2024-09-30	$1,839,930	567,880	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.